Bioequivalence and Bioavailability Forum 11:14 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Study costs: Replicate vs. 2×2×2 [Regulatives / Guidelines]

posted by mahmoud-teaima - 2017-03-23 08:17  - Posting: # 17178
Views: 16,914

Hi Helmut,

» Calculation of costs is complicated (fixed & variable costs, blahblah). In my CRO we had a spreadsheet with 100 rows… Had a quick look (19 samples / period, last sampling 16 hours; 2×2×2 in 42 subjects vs. 2×2×4 in 22). The replicate design would be ~4% cheaper. ;-) If you hope for RSABE (for CVwR 31% 18 subjects instead of 22 for ABE) the reduction in costs would be ~12%.

Can you please help me for in the approximate estimation of cost of bioequivalence study?, would you please send me the template sheet that you use for such calculations.

Greetings.

Mahmoud Teaima, PhD.

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,016 posts in 4,056 threads, 1,294 registered users;
online 12 (0 registered, 12 guests [including 8 identified bots]).

The scientist only imposes two things, namely truth and sincerity,
imposes them upon himself and upon other scientists.    Erwin Schrödinger

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed